Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 534 of 5804
-
New trial aims to tailor breast cancer therapy using genetic tests
Disease control Recruiting nowThis study aims to utilize a novel biomarker-driven approach to guide neoadjuvant treatment selection. It is the hypothesis that this will improve clinical response for postmenopausal women with clinical stage II/III ER-positive, HER2-negative breast cancer and identify those who…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New liposomal drug combo aims to boost lymphoma remission
Disease control Recruiting nowThis is a prospective clinical study to evaluate the safety and efficacy of R-CMOP in patients with newly diagnosed diffuse large B-cell lymphoma
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug may boost motor skills in kids with SMA after gene therapy
Disease control Recruiting nowThis is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered as an early intervention in pediatric participants with spinal muscular atrophy (SMA) and 2 SMN2 copies who have previously received onasemnogene abepa…
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular degeneration (AMD). The main questions it aims to answer are: what is the rate of change in the macular area of photoreceptor loss in …
Phase: PHASE3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo shows promise for rare breast cancer type
Disease control Recruiting nowThis phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers. Neratinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnorm…
Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:55 UTC
-
New hope for advanced cancer patients with CLDN18.2 marker
Disease control Recruiting nowThis study consists of two research phases: Phase Ib (includes dose escalation stage and efficacy expansion stage): To explore the safety, tolerability and initial efficacy of SHR-A1904 in the treatment of CLDN18.2-positive advanced solid tumors, and to determine the recommended…
Phase: PHASE1 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Fewer eye injections possible? new study tests Higher-Dose aflibercept for DME
Disease control CompletedResearchers are looking for a better way to treat people who have diabetic macular edema. Diabetic macular edema (DME) is a diabetes-related eye disorder. In DME, the macula, which is the central part of the retina at the back of the eye, swells up resulting in vision problems. …
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to help kids with stiff heart muscle breathe easier
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Immunotherapy plus chemo takes on tough breast cancer
Disease control Recruiting nowTo look at the effectiveness of the combination of pembrolizumab, carboplatin, and paclitaxel in participants with stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered immune cells take on advanced cancers in early trial
Disease control Recruiting nowA clinical trial to assess the safety and efficacy of engineered Tumor Infiltrating Lymphocytes (TIL) for the treatment of Advanced Malignant Solid Tumors
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New device aims to zap away chronic migraine pain
Symptom relief OngoingProspective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.
Phase: NA • Sponsor: ShiraTronics • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New study aims to prevent Life-Threatening birth complications in black and hispanic mothers
Disease control Recruiting nowThe purpose of this study is to test the effectiveness of an integrated care model approach at two different levels of intensity designed to facilitate timely, appropriate care to reduce risk for SMM. Black and Hispanic pregnant patients with an Obstetrics-Comorbidity Index Score…
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail targets rare, aggressive melanoma
Disease control ENROLLING_BY_INVITATIONThis study was a phase IB, single-center, open-label, two part(part A involved dose reduction, and part B involved cohort expansion) clinical trial evaluating the safety and clinical activity of AK104 or AK112 in combination with axitinib in patients with advanced mucosal melanom…
Phase: PHASE1 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Wolbachia-Infected mosquitoes released to fight dengue, zika, and chikungunya
Prevention TerminatedMosquito-borne diseases cause suffering for hundreds of millions of people and claim more than 700,000 lives yearly. Diseases such as dengue, Zika, and chikungunya cause symptoms similar to malaria and are endemic in many parts of the world, yet there are no treatments for them n…
Phase: NA • Sponsor: Michigan State University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
Kangaroo care could slash sepsis risk in tiny newborns
Prevention Recruiting nowNeoDeco is a pragmatic, multicenter, parallel-group, cluster-randomised hybrid effectiveness-implementation trial designed to evaluate the impact of implementing optimised Kangaroo Care (KC) at the unit level compared to standard care in high-technology neonatal units. The trial …
Phase: NA • Sponsor: PENTA Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Can immune booster cells revive failing CAR-T therapy in leukemia?
Disease control Recruiting nowThis is a single-center, double-blind, randomized trial. Patients with relapsed or refractory acute B-lymphoblastic leukemia(r/r B-ALL) experiencing early functional exhaustion of CAR-T cells will be randomly allocated into three groups: the control cell group, the CIK treatment …
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug duo takes on tough lymphoma
Disease control Recruiting nowThe phase Ib part of this study aims to determine the recommended phase II dose (RP2D)of linperlisib in combination with chidamide for the treatment of peripheral T-cell lymphoma (PTCL). The phase IIa part is designed to evaluate the preliminary efficacy and safety of the linper…
Phase: PHASE1, PHASE2 • Sponsor: Yanyan Liu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Zapping the spine and brain together may restore hand control after paralysis
Symptom relief Recruiting nowWhile physical exercise remains the foundation for any rehabilitation therapy, the team seeks to improve the benefits of exercise by combining it with the concept of "Fire Together, Wire Together" - when brain stimulation is synchronized with spinal cord stimulation, nerve circui…
Phase: NA • Sponsor: Bronx VA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New drug cocktails aim to shrink Hard-to-Treat gut cancers
Disease control Recruiting nowThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC) or with novel agents. The current subprotocols include the following: Subpro…
Phase: PHASE1, PHASE2 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
App aims to turn bystanders into lifesavers against opioid overdoses
Prevention CompletedThe pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challen…
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC